The collection of symptoms that is the metabolic syndrome — insulin resistance, high cholesterol, fatty liver, and a greater risk for diabetes, heart disease, and stroke — are all related to obesity, but, according to a new review in the March 9th issue of the Cell Press publication “Trends in …

A new intravascular ultrasonography (IVUS) study has found that the metabolic syndrome is associated with accelerated plaque progression, but this is attributed to the individual component risk factors rather than the presence of the syndrome itself.

Purchases of cholesterol and diabetes prescription drugs by elderly Medicare beneficiaries reached nearly $19 billion in 2007 — about one-fourth of the approximately $82 billion spent for medications for the elderly, according to the latest AHRQ News and Numbers.

Drinking coffee cuts diabetes risk, new research confirms, but you may need to enjoy your java with lunch if you want to get any benefit. 

Diabetic retinopathy, the leading cause of blindness in the working-age population, could be associated with poorer memory and diminished brain power in people with Type 2 diabetes, according to new research.

A new published study shows that primary care physicians believe the barriers that put patients with uncontrolled diabetes at risk for cardiovascular disease as being patient-related or system-related….

The obesity epidemic is a concern for experts around the world. One of the major problems is high levels of lipids in the blood, which can lead to cardiovascular disease, fatty liver disease and Type 2 diabetes. But a University of Alberta researcher has taken a major step in protecting …

Salt and preservatives may be the culprits, researchers suggest.

It’s a silent epidemic that affects millions of Americans. Chronic Kidney Disease (CKD) is a life-threatening illness that can often be treated successfully if found early, and can be detected at an early stage using simple, inexpensive blood and urine tests. According to DNA physicians, tracking your “kidney number” is …

David Joffe, BSPharm, CDE, FACA Amylin, Lilly and Alkermes received a Complete Response Letter from FDA for Exenatide Once Weekly. New drug to be called BYDUREON (exenatide for extended-release injectable suspension).